SCHEMBL2642525

SCHEMBL2642525

[NH]Cc1ccccc1CO

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
APOBEC3G Q9HC16 1/20 0.48
PDCD1 Q15116 1/20 0.40
CD274 Q9NZQ7 1/20 0.40
TSHR P16473 2/20 0.39
CYP4F2 P78329 2/20 0.38
CYP4A11 Q02928 2/20 0.38
CYP2A6 P11509 1/20 0.38
HSPA5 P11021 1/20 0.36
TAAR1 Q96RJ0 1/20 0.36
HPGD P15428 3/20 0.35
HTT P42858 1/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ALDH1A1 P00352 1/20 0.34
IDO1 P14902 1/20 0.33
MAOB P27338 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28375849 0.85 APOBEC3G (0.55) APOBEC3GPDCD1CD274TSHRCYP4F2
SCHEMBL29366632 0.85 APOBEC3G (0.60) APOBEC3GPDCD1CD274TSHRCYP4F2
SCHEMBL1696970 0.85 HSPA5 (0.38) APOBEC3GTSHRHSPA5TAAR1HTT
SCHEMBL41139 0.85 APOBEC3G (0.60) APOBEC3GPDCD1CD274TSHRCYP4F2
SCHEMBL8142723 0.79 TDP1 (0.44) APOBEC3GTSHRCYP4F2CYP4A11HSPA5
SCHEMBL7559665 0.77 APOBEC3G (0.59) APOBEC3GCYP2A6LMNAALDH1A1
SCHEMBL3289222 0.77 HSPA5 (0.52) APOBEC3GPDCD1CD274TSHRCYP4F2
Hydrochloric Acid SCHEMBL8987512 0.76 DPP4 (0.50) APOBEC3GPDCD1CD274TSHRCYP4F2
SCHEMBL10778277 0.75 POLB (0.38) APOBEC3GTSHRCYP4F2CYP4A11
SCHEMBL6244844 0.74 TSHR (0.63) APOBEC3GPDCD1CD274TSHRCYP4F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8765789-B2 2-pyridinecarboxamide derivatives MSD K.K. (JP) 2014-07-01 US disclosed
US-20130085156-A1 NOVEL 2-PYRIDINECARBOXAMIDE DERIVATIVES MSD K.K. (JP) 2013-04-04 US disclosed
US-8344003-B2 2-pyridinecarboxamide derivatives MSD K. K. (JP) 2013-01-01 US disclosed
US-20100041660-A1 NOVEL 2-PYRIDINECARBOXAMIDE DERIVATIVES MSD K.K. (JP) 2010-02-18 US disclosed
US-7629362-B2 2-pyridine carboxamide derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 2009-12-08 US disclosed
US-20060258701-A1 Novel 2-pyridinecarboxamide derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 2006-11-16 US disclosed
EP-1598349-A1 NOVEL 2-PYRIDINECARBOXAMIDE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 2005-11-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130085156-A1 NOVEL 2-PYRIDINECARBOXAMIDE DERIVATIVES GCKR, GCK, HK2 APOBEC3G 4503/4885PDCD1 4587/4885CD274 4847/4885
US-20060258701-A1 Novel 2-pyridinecarboxamide derivatives GCKR, GCK, HK2 APOBEC3G 4501/4885PDCD1 4589/4885CD274 4845/4885
US-20100041660-A1 NOVEL 2-PYRIDINECARBOXAMIDE DERIVATIVES GCKR, GCK, HK2 APOBEC3G 4503/4885PDCD1 4587/4885CD274 4847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.